EMAIL THIS PAGE TO A FRIEND

The Journal of neuroscience : the official journal of the Society for Neuroscience

Inducible activation of ERK5 MAP kinase enhances adult neurogenesis in the olfactory bulb and improves olfactory function.


PMID 25995470

Abstract

Recent discoveries have suggested that adult neurogenesis in the subventricular zone (SVZ) and olfactory bulb (OB) may be required for at least some forms of olfactory behavior in mice. However, it is unclear whether conditional and selective enhancement of adult neurogenesis by genetic approaches is sufficient to improve olfactory function under physiological conditions or after injury. Furthermore, specific signaling mechanisms regulating adult neurogenesis in the SVZ/OB are not fully defined. We previously reported that ERK5, a MAP kinase selectively expressed in the neurogenic regions of the adult brain, plays a critical role in adult neurogenesis in the SVZ/OB. Using a site-specific knock-in mouse model, we report here that inducible and targeted activation of the endogenous ERK5 in adult neural stem/progenitor cells enhances adult neurogenesis in the OB by increasing cell survival and neuronal differentiation. This conditional ERK5 activation also improves short-term olfactory memory and odor-cued associative olfactory learning under normal physiological conditions. Furthermore, these mice show enhanced recovery of olfactory function and have more adult-born neurons after a zinc sulfate-induced lesion of the main olfactory epithelium. We conclude that ERK5 MAP kinase is an important endogenous signaling pathway regulating adult neurogenesis in the SVZ/OB, and that conditional activation of endogenous ERK5 is sufficient to enhance adult neurogenesis in the OB thereby improving olfactory function both under normal conditions and after injury.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1306375
ANTI-ERK4(C-TERMINAL) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
E1523
Anti-ERK5 (big-MAPK, BMK1) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA027347
Anti-MAP2K5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab1
HPA027755
Anti-MAP2K5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2
SAB2106832
Anti-MAP2K5 antibody produced in rabbit, affinity isolated antibody
GW22769 Anti-MAPK7 (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW22770 Anti-MAPK7 (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
E7153 Anti-phospho-ERK5 (pThr218/pTyr220) antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
R4904 Anti-Reelin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
WH0005607M1
Monoclonal Anti-MAP2K5 antibody produced in mouse, clone M1-E6, purified immunoglobulin, buffered aqueous solution
SAB1409527
Monoclonal Anti-MAP2K5 antibody produced in mouse, clone 1E5, purified immunoglobulin, buffered aqueous solution
SAB1404254
Monoclonal Anti-MAP2K5, (N-terminal) antibody produced in mouse, clone 3E10, purified immunoglobulin, buffered aqueous solution
SAB4100165
Monoclonal Anti-MAPK7 antibody produced in mouse, clone MAPK7-B159, culture supernatant
O1376
Orotidine 5′-monophosphate trisodium salt, ≥99% (HPLC), powder
C10H10N2Na3O11P